Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.
Détails
Télécharger: 39485845.pdf (20978.65 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_20718CBE7864
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.
Périodique
Science advances
ISSN
2375-2548 (Electronic)
ISSN-L
2375-2548
Statut éditorial
Publié
Date de publication
11/2024
Peer-reviewed
Oui
Volume
10
Numéro
44
Pages
eadq3539
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
The intricate process of α-synuclein aggregation and fibrillization holds pivotal roles in Parkinson's disease (PD) and multiple system atrophy (MSA). While mouse α-synuclein can fibrillize in vitro, whether these fibrils commonly used in research to induce this process or form can reproduce structures in the human brain remains unknown. Here, we report the first atomic structure of mouse α-synuclein fibrils, which was solved in parallel by two independent teams. The structure shows striking similarity to MSA-amplified and PD-associated E46K fibrils. However, mouse α-synuclein fibrils display altered packing arrangements, reduced hydrophobicity, and heightened fragmentation sensitivity and evoke only weak immunological responses. Furthermore, mouse α-synuclein fibrils exhibit exacerbated pathological spread in neurons and humanized α-synuclein mice. These findings provide critical insights into the structural underpinnings of α-synuclein pathogenicity and emphasize a need to reassess the role of mouse α-synuclein fibrils in the development of related diagnostic probes and therapeutic interventions.
Mots-clé
alpha-Synuclein/metabolism, alpha-Synuclein/chemistry, Humans, Animals, Mice, Lewy Body Disease/metabolism, Lewy Body Disease/pathology, Parkinson Disease/metabolism, Parkinson Disease/pathology, Amyloid/metabolism, Amyloid/chemistry, Mice, Transgenic, Models, Molecular, Multiple System Atrophy/metabolism, Multiple System Atrophy/pathology, Disease Models, Animal, Neurons/metabolism, Neurons/pathology, Brain/metabolism, Brain/pathology
Pubmed
Open Access
Oui
Création de la notice
11/11/2024 15:47
Dernière modification de la notice
12/11/2024 7:09